Shetty Amith, Sparenberg Sebastian, Adams Kristian, Selvedran Selwyn, Tang Benjamin, Hanna Kim, Iredell Jonathan
Emergency Department, Westmead Hospital, Sydney, New South Wales, Australia.
Critical Infection and Immunology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
Emerg Med Australas. 2018 Dec;30(6):794-801. doi: 10.1111/1742-6723.13095. Epub 2018 May 13.
The arterial to end-tidal carbon dioxide tension difference (CO gap) correlates with physiologic dead space. The prognostic value of increased CO gap in trauma and respiratory distress patients is documented. Transpulmonary arteriovenous shunting is identified as a predictor of mortality in non-pulmonary sepsis. We set out to investigate the prognostic value of the CO gap in a pilot study of patients with suspected sepsis from non-respiratory causes.
Patients presenting to tertiary Australian ED with suspected sepsis (n = 215) underwent near-simultaneous end-tidal carbon dioxide and partial pressure of carbon dioxide measurements. We investigated the correlation of CO gap levels with the primary outcome of in-hospital mortality (IHM) and secondary outcomes of sepsis (ΔSOFA ≥2) and IHM and/or intensive care unit stay ≥72 h (IHM/ICU72h) in patients with sepsis because of non-respiratory causes.
Among patients included in the analysis (n = 165), the CO gap showed modest positive correlation with qSOFA (ρ = 0.39) and weak positive correlation with SOFA scores (ρ = 0.29) (both P < 0.01). The CO gap had modest predictive value for primary outcome (IHM), area under receiver operating curve (AUROC 0.85, 95% confidence interval [CI] 0.78-0.90) and IHM/ICU72h outcome (AUROC 0.80, 95% CI 0.73-0.86), but lower predictive value for sepsis outcome (AUROC 0.64, 95% CI 0.55-0.71) (all P < 0.001). We report modest test performance for primary outcome at CO gap ≥5 and ≥10 mmHg cut-offs.
In this pilot study of patients with suspected sepsis from non-respiratory causes, an increased CO gap demonstrates value in risk stratification and needs to be further evaluated and compared to other existent biomarkers.
动脉血与呼气末二氧化碳分压差值(CO₂差值)与生理死腔相关。创伤和呼吸窘迫患者中CO₂差值升高的预后价值已有文献记载。经肺动静脉分流被确定为非肺部脓毒症患者死亡率的预测指标。我们开展了一项初步研究,旨在调查CO₂差值对疑似非呼吸道原因脓毒症患者的预后价值。
因疑似脓毒症就诊于澳大利亚三级急诊科的患者(n = 215)接受了几乎同步的呼气末二氧化碳和二氧化碳分压测量。我们研究了CO₂差值水平与非呼吸道原因脓毒症患者的主要结局(院内死亡率[IHM])以及脓毒症的次要结局(序贯器官衰竭评估[SOFA]评分增加≥2)和IHM以及入住重症监护病房≥72小时(IHM/ICU72h)之间的相关性。
在纳入分析的患者(n = 165)中,CO₂差值与快速序贯器官衰竭评估(qSOFA)呈中度正相关(ρ = 0.39),与SOFA评分呈弱正相关(ρ = 0.29)(均P < 0.01)。CO₂差值对主要结局(IHM)、受试者工作特征曲线下面积(AUROC 0.85,95%置信区间[CI] 0.78 - 0.90)和IHM/ICU72h结局(AUROC 0.80,95% CI 0.73 - 0.86)具有中度预测价值,但对脓毒症结局的预测价值较低(AUROC 0.64,95% CI 0.55 - 0.71)(均P < 0.001)。我们报告了在CO₂差值≥5和≥10 mmHg临界值时主要结局的适度检验效能。
在这项针对疑似非呼吸道原因脓毒症患者的初步研究中,升高的CO₂差值在风险分层中显示出价值,需要进一步评估并与其他现有生物标志物进行比较。